A new study by researchers at the University of Manchester has revealed that a unique microbiome signature can be used to diagnose Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The research, published in the journal Nature Communications, has shown that identifying and measuring the levels of certain bacteria in the gut could be used as a biomarker for ME/CFS, which currently has no reliable diagnostic test. This could lead to faster, more effective diagnosis and better treatment for this debilitating condition.

Read Full Article Here

source: Phys.org